| . "Estimating personalized diagnostic rules depending on individualized characteristics.." Stat Med. 2017;36(7):1099-1117. Pub Med |
| . "Block-diagonal discriminant analysis and its bias-corrected rules.." Stat Appl Genet Mol Biol. 2013;12(3):347-59. Pub Med |
| . "Assessing the dependence of sensitivity and specificity on prevalence in meta-analysis.." Biostatistics. 2011;12(4):710-22. Pub Med |
| . "Time-dependent classification accuracy curve under marker-dependent sampling.." Biom J. 2016;58(4):974-92. Pub Med |
| . "A trivariate meta-analysis of diagnostic studies accounting for prevalence and non-evaluable subjects: re-evaluation of the meta-analysis of coronary CT angiography studies.." BMC Med Res Methodol. 2014;14():128. Pub Med |
| . "A unification of models for meta-analysis of diagnostic accuracy studies without a gold standard.." Biometrics. 2015;71(2):538-47. Pub Med |
| . "Multicategory reclassification statistics for assessing improvements in diagnostic accuracy.." Biostatistics. 2013;14(2):382-94. Pub Med |
| . "Performance of rapid influenza H1N1 diagnostic tests: a meta-analysis.." Influenza Other Respir Viruses. 2012;6(2):80-6. Pub Med |
| . "A simple and robust method for multivariate meta-analysis of diagnostic test accuracy.." Stat Med. 2017;36(1):105-121. Pub Med |
| . "Comparison of operational characteristics for binary tests with clustered data.." Stat Med. 2015;34(15):2325-33. Pub Med |
| . "Statistical methods for multivariate meta-analysis of diagnostic tests: An overview and tutorial.." Stat Methods Med Res. 2016;25(4):1596-619. Pub Med |
| . "A hybrid Bayesian hierarchical model combining cohort and case-control studies for meta-analysis of diagnostic tests: Accounting for partial verification bias.." Stat Methods Med Res. 2016;25(6):3015-3037. Pub Med |
| . "A composite likelihood method for bivariate meta-analysis in diagnostic systematic reviews.." Stat Methods Med Res. 2017;26(2):914-930. Pub Med |
| . "Trastuzumab emtansine versus capecitabine plus lapatinib in patients with previously treated HER2-positive advanced breast cancer (EMILIA): a descriptive analysis of final overall survival results from a randomised, open-label, phase 3 trial.." Lancet Oncol. 2017;18(6):732-742. Pub Med |
| . "More insights into early brain development through statistical analyses of eigen-structural elements of diffusion tensor imaging using multivariate adaptive regression splines.." Brain Struct Funct. 2014;219(2):551-69. Pub Med |
| . "Provider-based research networks and diffusion of surgical technologies among patients with early-stage kidney cancer.." Cancer. 2015;121(6):836-43. Pub Med |
| . "Incorporating covariates in skewed functional data models.." Biostatistics. 2015;16(3):413-26. Pub Med |
| . "More insights into early brain development through statistical analyses of eigen-structural elements of diffusion tensor imaging using multivariate adaptive regression splines.." Brain Struct Funct. 2014;219(2):551-69. Pub Med |
| . "Diffusion tensor imaging-based characterization of brain neurodevelopment in primates.." Cereb Cortex. 2013;23(1):36-48. Pub Med |
| . "A longitudinal functional analysis framework for analysis of white matter tract statistics.." Inf Process Med Imaging. 2013;23():220-31. Pub Med |
| . "Multivariate varying coefficient models for DTI tract statistics.." Med Image Comput Comput Assist Interv. 2010;13(Pt 1):690-7. Pub Med |
| . "FMEM: Functional mixed effects modeling for the analysis of longitudinal white matter Tract data.." Neuroimage. 2014;84():753-64. Pub Med |
| . "Longitudinal regression analysis of spatial-temporal growth patterns of geometrical diffusion measures in early postnatal brain development with diffusion tensor imaging.." Neuroimage. 2011;58(4):993-1005. Pub Med |
| . "Semiparametric Bayesian local functional models for diffusion tensor tract statistics.." Neuroimage. 2012;63(1):460-74. Pub Med |
| . "FADTTS: Functional analysis of diffusion tensor tract statistics.." Neuroimage. 2011;56(3):1412-25. Pub Med |
| . "Estimating personalized diagnostic rules depending on individualized characteristics.." Stat Med. 2017;36(7):1099-1117. Pub Med |
| . "Confident difference criterion: a new Bayesian differentially expressed gene selection algorithm with applications.." BMC Bioinformatics. 2015;16():245. Pub Med |
| . "Analysing breast cancer microarrays from African Americans using shrinkage-based discriminant analysis.." Hum Genomics. 2010;5(1):5-16. Pub Med |
| . "Block-diagonal discriminant analysis and its bias-corrected rules.." Stat Appl Genet Mol Biol. 2013;12(3):347-59. Pub Med |
| . "Biclustering via sparse clustering.." Biometrics. 2020;76(1):348-358. Pub Med |
| . "A general framework for studying genetic effects and gene-environment interactions with missing data.." Biostatistics. 2010;11(4):583-98. Pub Med |
| . "Improving the efficiency of estimation in the additive hazards model for stratified case-cohort design with multiple diseases.." Stat Med. 2016;35(2):282-93. Pub Med |
| . "Application of a sequential multiple assignment randomized trial (SMART) design in older patients with chronic lymphocytic leukemia.." Ann Oncol. 2019;30(4):542-550. Pub Med |
| . "Penalized nonlinear mixed effects model to identify biomarkers that predict disease progression.." Biometrics. 2017;73(4):1343-1354. Pub Med |
| . "Multiple kernel learning with random effects for predicting longitudinal outcomes and data integration.." Biometrics. 2015;71(4):918-28. Pub Med |
| . "Phase II, randomized, placebo-controlled study of dovitinib in combination with fulvestrant in postmenopausal patients with HR(+), HER2(-) breast cancer that had progressed during or after prior endocrine therapy.." Breast Cancer Res. 2017;19(1):18. Pub Med |
| . "Systematic review and network meta-analysis comparing palbociclib with chemotherapy agents for the treatment of postmenopausal women with HR-positive and HER2-negative advanced/metastatic breast cancer.." Breast Cancer Res Treat. 2017;166(1):167-177. Pub Med |
| . "Celecoxib with neoadjuvant chemotherapy for breast cancer might worsen outcomes differentially by COX-2 expression and ER status: Exploratory analysis of the REMAGUS02 trial.." J Clin Oncol. 2019;37(8):624-635. Pub Med |
| . "Bayesian gamma frailty models for survival data with semi-competing risks and treatment switching.." Lifetime Data Anal. 2014;20(1):76-105. Pub Med |
| . "Sex differences in grey matter atrophy patterns among AD and aMCI patients: results from ADNI.." Neuroimage. 2011;56(3):890-906. Pub Med |
| . "Assessing temporal agreement between central and local progression-free survival times.." Stat Med. 2015;34(5):844-58. Pub Med |
| . "Additive mixed effect model for clustered failure time data.." Biometrics. 2011;67(4):1340-51. Pub Med |
| . "Bayesian influence measures for joint models for longitudinal and survival data.." Biometrics. 2012;68(3):954-64. Pub Med |
| . "Empirical pathway analysis, without permutation.." Biostatistics. 2013;14(3):573-85. Pub Med |
| . "Bayesian methods in clinical trials: A Bayesian analysis of ECOG trials E1684 and E1690.." BMC Med Res Methodol. 2012;12():183. Pub Med |
| . "Multitrial evaluation of progression-free survival as a surrogate end point for overall survival in first-line extensive-stage small-cell lung cancer.." J Thorac Oncol. 2015;10(7):1099-106. Pub Med |
| . "Trastuzumab emtansine versus capecitabine plus lapatinib in patients with previously treated HER2-positive advanced breast cancer (EMILIA): a descriptive analysis of final overall survival results from a randomised, open-label, phase 3 trial.." Lancet Oncol. 2017;18(6):732-742. Pub Med |
| . "Validation of progression-free survival as a surrogate endpoint for overall survival in malignant mesothelioma: Analysis of Cancer and Leukemia Group B and North Central Cancer Treatment Group (Alliance) Trials.." Oncologist. 2017;22(2):189-198. Pub Med |
| . "Assessing temporal agreement between central and local progression-free survival times.." Stat Med. 2015;34(5):844-58. Pub Med |
| . "Phase II clinical trials with time-to-event endpoints: optimal two-stage designs with one-sample log-rank test.." Stat Med. 2014;33(12):2004-16. Pub Med |
